"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Descriptor ID |
D003362
|
MeSH Number(s) |
N03.219.151.125
|
Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 0 | 4 | 4 |
1998 | 0 | 4 | 4 |
2000 | 0 | 3 | 3 |
2002 | 0 | 2 | 2 |
2004 | 0 | 3 | 3 |
2005 | 0 | 2 | 2 |
2006 | 0 | 3 | 3 |
2007 | 0 | 2 | 2 |
2008 | 0 | 2 | 2 |
2010 | 0 | 3 | 3 |
2011 | 2 | 4 | 6 |
2012 | 0 | 6 | 6 |
2013 | 1 | 4 | 5 |
2014 | 0 | 12 | 12 |
2015 | 2 | 7 | 9 |
2016 | 0 | 8 | 8 |
2017 | 1 | 2 | 3 |
2018 | 0 | 3 | 3 |
2019 | 0 | 5 | 5 |
2020 | 1 | 4 | 5 |
2021 | 1 | 3 | 4 |
2022 | 0 | 5 | 5 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
An Efficient and Cost-Effective Approach to Generate Functional Human Inducible Pluripotent Stem Cell-Derived Astrocytes. Cells. 2023 09 26; 12(19).
-
Off-pump injectable versus on-pump conventional tissue valves for pulmonary valve replacement: the injectable valve implantation randomised trial (INVITE). BMJ Open. 2023 06 01; 13(6):e065192.
-
The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review. J Allergy Clin Immunol Pract. 2022 08; 10(8):2109-2116.
-
The Cost-Effectiveness of Tibial Metaphyseal Cones in Revision Total Knee Arthroplasty. J Arthroplasty. 2022 06; 37(6S):S50-S55.
-
Commentary: Robotic-Assisted vs Nonrobotic-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Cost-Utility Analysis. Neurosurgery. 2022 02 01; 90(2):e32-e33.
-
Rotator Cuff Repair with Graft Augmentation Improves Function, Decreases Revisions, and Is Cost-Effective. Arthroscopy. 2022 07; 38(7):2166-2174.
-
Management of Atrial Fibrillation in Patients 75 Years and Older: JACC?State-of-the-Art?Review. J Am Coll Cardiol. 2022 01 18; 79(2):166-179.
-
Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States. Clin Infect Dis. 2021 11 02; 73(9):e3355-e3357.
-
A Practical Guide to Understanding Cost-Effectiveness Analyses. J Allergy Clin Immunol Pract. 2021 12; 9(12):4200-4207.
-
Inadequate Selection and Treatment Results in Poor Outcomes and Lack of Cost-Effectiveness. Value Health. 2021 08; 24(8):1234-1235.